Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schoemaker Kathleen K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   8,715,548    

Indirect Shares

   3,038,103      
Direct Value   $234,309,114    

Indirect Value

   $11,375,435      
Total Shares   11,753,651      
Total Value   $245,684,549      


Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $233,213,171 Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $233,213,171
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 29,887 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 2014-02-12 2,972,678 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 9,058 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-01-16 3,590,931 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-04 44,034 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 2,068,960 2015-06-30 0    Premium*  
* Premium Members only  

Records found :    282         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 D $0.00 $0 I/I (1,000,000) 5,772,968 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-18 4 AS $5.19 $99,025 D/D (19,080) 2,702,345 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 A $0.00 $0 I/I 66,462 159,896 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-18 4 AS $5.19 $3,275 D/D (631) 89,320 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-22 4 AS $5.02 $231,688 D/D (46,153) 8,288,347 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-22 4 AS $5.02 $2,485 D/D (495) 88,825 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-22 4 AS $5.02 $75,129 D/D (14,966) 2,687,379 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-22 4 AS $5.02 $1,275 D/D (254) 45,842 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-23 4 AS $5.11 $129,559 D/D (25,354) 2,662,025 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-23 4 AS $5.11 $2,197 D/D (430) 45,412 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-23 4 AS $5.11 $4,287 D/D (839) 87,986 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-23 4 AS $5.11 $399,541 D/D (78,188) 8,210,159 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-24 4 AS $5.45 $197,966 D/D (36,324) 2,625,701 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-24 4 AS $5.45 $6,545 D/D (1,201) 86,785 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-24 4 AS $5.45 $3,357 D/D (616) 44,796 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-24 4/A AS $5.45 $610,520 D/D (112,022) 8,098,137 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-24 4 AS $5.45 $605,070 D/D (111,022) 8,098,137 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-25 4 AS $5.38 $2,453 D/D (456) 86,329 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-25 4 AS $5.38 $74,190 D/D (13,790) 2,611,911 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-25 4 AS $5.38 $228,785 D/D (42,525) 8,055,612 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-25 4 AS $5.38 $1,259 D/D (234) 44,562 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-28 4 AS $5.40 $277,436 D/D (51,377) 8,004,235 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-28 4 AS $5.40 $89,964 D/D (16,660) 2,595,251 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-28 4 AS $5.40 $2,975 D/D (551) 85,778 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-01-28 4 AS $5.40 $1,523 D/D (282) 44,280 0 -
  282  Records found
  1   2   3   4   5  6   7   8   9   10   11   12      
  Page 5 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us